title: ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.
abstract: In 2001, the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis. The American College of Obstetricians and Gynecologists' Committee on Genetics has updated current guidelines for cystic fibrosis screening practices among obstetrician-gynecologists.
mesh_terms: D003376:Counseling; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005260:Female; D005820:Genetic Testing / Q000592:standards*; D006579:Heterozygote; D006801:Humans; D009774:Obstetrics / Q000592:standards; D010353:Patient Education as Topic / Q000592:standards; D010375:Pedigree; D017410:Practice Guidelines as Topic; D016742:Preconception Care / Q000592:standards; D011247:Pregnancy; D011295:Prenatal Care / Q000592:standards; D018570:Risk Assessment; D012955:Societies, Medical / Q000592:standards; D014481:United States
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator